VU-1545

CAS No. 890764-63-3

VU-1545( VU 1545 )

Catalog No. M27735 CAS No. 890764-63-3

VU 1545 is mGlu5 positive allosteric modulator.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 46 In Stock
5MG 79 In Stock
10MG 126 In Stock
25MG 244 In Stock
50MG 369 In Stock
100MG 532 In Stock
200MG 714 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    VU-1545
  • Note
    Research use only, not for human use.
  • Brief Description
    VU 1545 is mGlu5 positive allosteric modulator.
  • Description
    VU 1545 is mGlu5 positive allosteric modulator.
  • In Vitro
    VU-1545 (10 and 100 μM) promotes AKT activation. VU-1545 at the concentrations of 0.1 and 1.0 μM efficiently promots Akt activation above basal levels Western Blot Analysis Cell Line:Neuronal cells Concentration:10 and 100 μM Incubation Time:5 minutes Result:Promoted Akt phosphorylation as efficiently at the concentration of 10.0 μM as at the concentration of 100.0 μM.
  • In Vivo
    ——
  • Synonyms
    VU 1545
  • Pathway
    Neuroscience
  • Target
    GluR
  • Recptor
    Microbial Metabolite|TGR5|FXR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    890764-63-3
  • Formula Weight
    402.385
  • Molecular Formula
    C22H15FN4O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (248.52 mM)
  • SMILES
    [O-][N+](=O)c1ccc(cc1)C(=O)Nc1cc(nn1-c1ccccc1F)-c1ccccc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Jones H, Alpini G, Francis H. Bile acid signaling and biliary functions. Acta Pharm Sin B. 2015 Mar;5(2):123-8.
molnova catalog
related products
  • LY2608204

    LY2608204 has been used in trials studying the treatment of Diabetes Mellitus, Type 2.

  • 1-ethyl-3-morpholin-...

    1-ethyl-3-morpholin-4-yl-5,6,7,8-tetrahydroisoquinoline-4-carbonitrile is a positive allosteric modulator of mGluR3 and can be used in studies about the treatment of Parkinson's disease.

  • Memantine hydrochlor...

    Memantine is an uncompetitive NMDA receptor antagonist. When using HEK293 cells express recombinant rat NMDA receptors, memantine shows inhibition of L-glutamate-mediated response with a dose- and voltage-dependent manner.